Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Aging Committee leaders cheer bipartisanship
By
Lois A. Bowers
Nov 30, 2016
As the ranking member of the Senate Special Committee on Aging prepares to depart from that role, she and the committee’s chairwoman celebrated what can be accomplished when Republicans and Democrats...
Robotic pets curb social isolation for older adults during COVID-19 pandemic
By
Kimberly Bonvissuto
May 01, 2020
Robotic cats and dogs are being used in Florida and New York to help older adults in senior living communities, individual homes and apartments combat the effects of social isolation during the COVID-19...
Health habits’ connection to dementia in the spotlight as new year begins
By
Lois A. Bowers
Jan 04, 2022
An update to the National Plan to Address Alzheimer’s Disease, as well as news of potential treatments and a finding that “astonished” researchers add up to promising news to start the new...
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
A high-fiber diet may reduce dementia risks later in life
By
John O'Connor
Apr 01, 2022
The mechanisms still remain unknown but could involve interactions taking place between the gut and brain.
Alzheimer’s film: Not many surprises for you, but maybe some for general public
By
Lois A. Bowers
Jan 30, 2017
Those who care for residents with Alzheimer’s disease every day shouldn’t expect many surprises from a new PBS documentary, “Alzheimer’s: Every Minute Counts.” But you still...
‘Movie Moments’ event aims to increase inclusivity, decrease stigma around dementia
By
Sean Caulfield
Nov 20, 2017
An event featuring classic movies addresses how inclusion applies to individuals living with Alzheimer’s disease and other forms of dementia.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).